Published February 26, 2022 | Version v1

Specific mutations in the cholesterol-binding site of APP alter its processing and favor the production of shorter, less toxic Aβ peptides.

Authors/Creators

  • 1. ICM, PARIS BRAIN INSTITUTE

Contributors

Researcher:

  • 1. Gothenburg Univ

Description

Mass Spectrometry data of Abeta secreted peptides from HEK293 stable clones expressing APP or APPK28A treated or not with methylbetacyclodextrin-cholesterol.

Files

Files (56.9 kB)

Name Size Download all
md5:0dc4f55dc03029634f355e9dd0a916fa
56.9 kB Download

Additional details

Related works

Is cited by
Journal article: 10.1101/2020.11.16.384891 (DOI)